Results 161 to 170 of about 2,220 (203)

The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer. [PDF]

Sci Rep
Zhang W, Wang R, Guo R, Wang Y, Wang H, Li Y, Li X, Song J.   +7 more
europepmc   +1 more source

Dominant Expression of Chromogranin B in Pituitary Corticotrophs and Its Putative Role in Interaction With Secretogranin III. [PDF]

J Histochem Cytochem
Kikuchi S, Odashima K, Yasui T, Torii S, Hosaka M, Gomi H.   +5 more
europepmc   +1 more source

Methylation alterations of imprinted genes in different placental diseases. [PDF]

Clin Epigenetics
Wang X, Liu Y, Wu Y, Lin C, Yang S, Yang Y, Chen D, Yu B.   +7 more
europepmc   +1 more source

Chromogranin A and cardiovascular function

Journal of Hypertension, 2011
openaire   +3 more sources

Secretogranin III: a promising therapeutic target for intraocular neovascular lesions. [PDF]

Int Ophthalmol
Yuan CY, Zuo L, Dong YC, Liu BX, Qi H.
europepmc   +1 more source

KRAS and GNAS mutations in cell-free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms-an observational pilot study. [PDF]

Mol Oncol
Nitschke C, Tölle M, Walter P, Meißner K, Goetz M, Kropidlowski J, Berger AW, Izbicki JR, Nickel F, Hackert T, Pantel K, Wikman H, Uzunoglu FG.   +12 more
europepmc   +1 more source

Recurrent small variants in NESP55/NESPAS associated with broad GNAS methylation defects and pseudohypoparathyroidism type 1B. [PDF]

JCI Insight
Li D, Jan de Beur S, Hou C, Ruzhnikov MR, Seeley H, Cutting GR, Sheridan MB, Levine MA.   +7 more
europepmc   +1 more source

Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations. [PDF]

J Clin Oncol
Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, Ramms D, Zou J, Wishart B, Rull J, Baumgartner J, Kelly K, White R, Veerapong J, Hosseini M, Patel H, Botta G, Gutkind JS, Tiriac H, Kato S, Lowy AM.   +20 more
europepmc   +1 more source

The Golgi apparatus: adaptations to neuronal shape and functions. [PDF]

EMBO J
Subkhangulova A, Mikhaylova M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chromogranin A.

Clinical and investigative medicine. Medecine clinique et experimentale, 1995
Chromogranin A (CgA) is the major member of the granin family of acidic secretory glycoproteins that are expressed in all endocrine and neuroendocrine cells. Granins have been proposed to play multiple roles in the secretory process. Intracellularly, granins play a role in targeting peptide hormones and neurotransmitters to granules of the regulated ...
G N, Hendy, S, Bevan, M G, Mattei, A J, Mouland   +3 more
openaire   +3 more sources